Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
FLRT3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
GCC2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PUDP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MAML2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
PIK3CA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
USH2A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DENND4C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PSG1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UBA6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PCK1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC01482 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KIR2DS2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ANKRD10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RECQL5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ST3GAL2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ENPP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIR22 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC00882 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on